Results 221 to 230 of about 106,174 (376)

Registries on transcatheter edge‐to‐edge repair in heart failure: Current evidence and future perspectives

open access: yesEuropean Journal of Heart Failure, EarlyView.
Clinical evidence in transcatheter edge‐to‐edge valve repair. EF, ejection fraction; eGFR, estimated glomerular filtration rate; EROA, effective regurgitant orifice area; GDMT, guideline‐directed medical therapy; HF, heart failure; HHF, hospitalization for heart failure; LVEDV, left ventricular end‐diastolic volume; MR, mitral regurgitation; MVARC ...
Gianluigi Savarese   +13 more
wiley   +1 more source

The efficacy of PDE5 inhibitors in diabetic patients

open access: yesAndrology, Volume 11, Issue 2, Page 245-256, February 2023., 2023
Abstract Background Phosphodiesterase 5 inhibitors (PDE5i), since their introduction in the late 1990s, have proven their efficacy in treating several conditions, predominantly pulmonary hypertension and erectile dysfunction where they remain the first‐line therapeutic option.
Agnieszka Swiecicka
wiley   +1 more source

Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart

open access: yesEuropean Journal of Heart Failure, EarlyView.
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo   +22 more
wiley   +1 more source

Syncope with QT‐interval prolongation and T‐wave inversion in anterior and inferior leads: Foreboder of a life‐threatening condition?

open access: yesAnnals of Noninvasive Electrocardiology, Volume 28, Issue 1, January 2023., 2023
The patient’s ECG exhibited QT‐interval prolongation with T‐wave inversion in anterior and inferior leads that, together with CT‐pulmonary angiography findings, strongly suggested PE. This ECG pattern is crucial for diagnosing PE. Abstract Even though patients with pulmonary embolism usually present with respiratory distress and tachycardia, the ...
Jing‐Xiu Li   +3 more
wiley   +1 more source

Crow-Fukase Syndrome with Ischemic Cardiomyopathy.

open access: bronze, 2001
Yoshihiko Ichikawa   +8 more
openalex   +2 more sources

Importance of Mitral Valve Repair Associated With Left Ventricular Reconstruction for Patients With Ischemic Cardiomyopathy: A Real-Time Three-Dimensional Echocardiographic Study [PDF]

open access: bronze, 2003
Jian Qin   +11 more
openalex   +1 more source

Cardiac rhythm devices in heart failure with reduced ejection fraction – role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document

open access: yesEuropean Journal of Heart Failure, EarlyView.
Abstract Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision‐making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices
Biykem Bozkurt   +15 more
wiley   +1 more source

The diagnostic role of T wave morphology biomarkers in congenital and acquired long QT syndrome: A systematic review

open access: yesAnnals of Noninvasive Electrocardiology, Volume 28, Issue 1, January 2023., 2023
Numerous T wave morphology biomarkers, which can supplement QTc assessment in long QT syndrome (LQTS), have been identified. Their diagnostic capabilities include differentiation of genotypes, identification of concealed LQTS, differentiating acquired LQTS from congenital LQTS; and determining multichannel versus hERG channel blockade.
Daniel T. Tardo   +4 more
wiley   +1 more source

Accurate Classification of Non-ischemic Cardiomyopathy. [PDF]

open access: yesCurr Cardiol Rep, 2023
Wang Y, Jia H, Song J.
europepmc   +1 more source

Cardiac Angiotensin-(1-7) in Ischemic Cardiomyopathy [PDF]

open access: bronze, 2003
David B. Averill   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy